Carcinoid and neuroendocrine tumors of the colon and rectum

Clinics in Colon and Rectal Surgery

Volumn 19, Issue 2, 2006, Pages 45-48

  Chung, T Philip ^a   Hunt, Steven R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinoid; Colon; Neuroendocrine tumor; Rectum

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALPHA INTERFERON; FLUOROURACIL; OCTREOTIDE; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN; TECHNETIUM 99M;

BONE METASTASIS; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURVIVAL; CARCINOID; COLORECTAL SURGERY; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; GASTROINTESTINAL ENDOSCOPY; HUMAN; LABORATORY TEST; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; TREATMENT OUTCOME; TUMOR DIAGNOSIS; URINE LEVEL;

EID: 33744959121     PISSN: 15310043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-942343     Document Type: Review

References (37)

1. Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK. Carcinoid tumour. Lancet 1998;352: 799-805
2. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann NY Acad Sci 2004;1014:13-27
3. Zhao J, de Krijger RR, Meier D, et al. Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis. Am J Pathol 2000;157: 1431-1438
4. Pearse AG. The APUD concept and hormone production. Clin Endocrinol Metab 1980;9:211-222
5. Williams ED, Sandier M. The classification of carcinoid tumours. Lancet 1963;1:238-239
6. Kytola S, Hoog A, Nord B, et al. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids. Am J Pathol 2001;158:1803-1808
7. Duh QY, Hybarger CP, Geist R, et al. Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 1987;154:142-148
8. Jakobovitz O, Nass D, DeMarco L, et al. Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab 1996;81:3164-3167
9. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79:813-829
10. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-959
11. Hay DJ, Curt JR. Carcinoid tumour as a complication of ulcerative colitis. Postgrad Med J 1979;55:430-432
12. Dodd SM. Chronic ulcerative colitis complicated by atypical carcinoid tumour. J Clin Pathol 1986;39:913-916
13. Owen DA, Hwang WS, Thorlakson RH, Walli E. Malignant carcinoid tumor complicating chronic ulcerative colitis. Am J Clin Pathol 1981;76:333-338
14. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 28-2000. A 34-year-old man with ulcerative colitis and a large perirectal mass. N Engl J Med 2000;343:794-800
15. Berge T, Linell F. Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathol Microbiol Scand [A] 1976;84:322-330
16. Warner TF, O'Reilly G, Lee GA. Mesenteric occlusive lesion and ileal carcinoids. Cancer 1979;44:758-762
17. Marshall JB, Bodnarchuk G. Carcinoid tumors of the gut. Our experience over three decades and review of the literature. J Clin Gastroenterol 1993;16:123-129
18. Tormey WP, FitzGerald RJ. The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid. Postgrad Med J 1995;71:542-545
19. Eriksson B, Oberg K, Stridsberg M. Tumor markers in neuroendocrine tumors. Digestion 2000;62(Suppl 1):33-38
20. Janson ET, Holmberg L, Stridsberg M, et al. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol 1997;8:685-690
21. Pantongrag-Brown L, Buetow PC, Carr NJ, Lichtenstein JE, Buck JL. Calcification and fibrosis in mesenteric carcinoid tumor: CT findings and pathologic correlation. AJR Am J Roentgenol 1995;164:387-391
22. Modlin IM, Tang LH. Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). Gastroenterology 1997;112:583-590
23. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005;128:1717-1751
24. Ballantyne GH, Savoca PE, Flannery JT, Ahlman MH, Modlin IM. Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry. Cancer 1992;69:2400-2405
25. Crocetti E, Paci E. Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases. Eur J Cancer Prev 2003;12:191-194
26. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999;340:858-868
27. Hellman P, Lundstrom T, Ohrvall U, et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg 2002;26:991-997
28. Rosenberg JM, Welch JP. Carcinoid tumors of the colon. A study of 72 patients. Am J Surg 1985;149:775-779
29. Spread C, Berkel H, Jewell L, Jenkins H, Yakimets W. Colon carcinoid tumors. A population-based study. Dis Colon Rectum 1994;37:482-491
30. Jetmore AB, Ray JE, Gathright JB Jr, McMullen KM, Hicks TC, Timmcke AE. Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon Rectum 1992;35:717-725
31. Soga J. Carcinoids of the colon and ileocecal region: a statistical evaluation of 363 cases collected from the literature. J Exp Clin Cancer Res 1998;17:139-148
32. Mani S, Modlin IM, Ballantyne G, Ahlman H, West B. Carcinoids of the rectum. J Am Coll Surg 1994;179:231-248
33. Shirouzu K, Isomoto H, Kakegawa T, Morimatsu M. Treatment of rectal carcinoid tumors. Am J Surg 1990;160: 262-265
34. Koura AN, Giacco GG, Curley SA, Skibber JM, Feig BW, Ellis LM. Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastasis free survival. Cancer 1997;79:1294-1298
35. Sauven P, Ridge JA, Quan SH, Sigurdson ER. Anorectal carcinoid tumors. Is aggressive surgery warranted? Ann Surg 1990;211:67-71
36. Eriksson B, Arnberg H, Oberg K, et al. A polyclonal antiserum against chromogranin A and B - a new sensitive marker for neuroendocrine tumours. Acta Endocrinol (Copenh) 1990; 122:145-155
37. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995;169:36-42; discussion 42-33